Stay updated on RC48-ADC in Low HER2 Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.

Latest updates to the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe footer now shows Revision: v3.5.5, replacing the previous v3.5.4. This update signals a minor page revision without modifying the study details or navigation.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new Revision: v3.5.4 tag has been added, replacing the previous v3.5.3, indicating a minor update to the page version or template rather than to study data.SummaryDifference0.0%

- Check44 days agoChange Detected- The page footer revision/version was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check52 days agoChange DetectedFirst Hospital of China Medical University was added as a study site and First Affiliated Hospital of China Medical University was removed. The document revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check95 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor software update with no visible changes to study content.SummaryDifference0.0%

Stay in the know with updates to RC48-ADC in Low HER2 Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.